<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">26487539</PMID>
        <DateCompleted>
            <Year>2016</Year>
            <Month>09</Month>
            <Day>14</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>12</Month>
            <Day>02</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2045-2322</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>5</Volume>
                    <PubDate>
                        <Year>2015</Year>
                        <Month>Oct</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Scientific reports</Title>
                <ISOAbbreviation>Sci Rep</ISOAbbreviation>
            </Journal>
            <ArticleTitle>MiR-129-3p promotes docetaxel resistance of breast cancer cells via CP110 inhibition.</ArticleTitle>
            <Pagination>
                <MedlinePgn>15424</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/srep15424</ELocationID>
            <Abstract>
                <AbstractText>Docetaxel is commonly used as an effective chemotherapeutic agent in breast cancer treatment, but the underlying mechanisms of drug resistance are not fully understood. The purpose of this study was to investigate the possible role of miR-129-3p in breast cancer cell resistance to docetaxel. MiR-129 and miR-129-3p inhibitor were transfected into breast cancer cells to investigate their effects on chemoresistance to docetaxel. The function of miR-129-3p was evaluated by apoptosis, cell proliferation, and cell cycle assays. We found that miR-129-3p was up-regulated in MDA-MB-231/Doc cells, concurrent with CP110 down-regulation, compared to the parental MDA-MB-231 cells. In vitro drug sensitivity assays demonstrated that miR-129-3p inhibition sensitized MDA-MB-231/Doc and MCF-7 cells to docetaxel, whereas miR-129 overexpression enhanced MDA-MB-231 and MCF-7 cell resistance to docetaxel. Ectopic miR-129 expression reduced CP110 expression and the luciferase activity of a CP110 3' untranslated region-based reporter construct in MDA-MB-231 cells, suggesting that CP110 is a direct miR-129-3p target. We demonstrated that restoration of CP110 expression in MDA-MB-231 and MCF-7 cells by miR-129 overexpression rendered the cells sensitive to docetaxel. In a nude xenograft model, miR-129 up-regulation significantly decreased MDA-MB-231 cells' response to docetaxel. Our findings suggest that miR-129-3p down-regulation potentially sensitizes breast cancer cells to docetaxel treatment. </AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Yuan</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>The State Key Laboratory of Cancer Biology and Department of Oncology, Xijing Hospital, The Fourth Military Medical University, Xi'an 710032, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>The State Key Laboratory of Cancer Biology and Department of Biochemistry and Molecular Biology, The Fourth Military Medical University, Xi'an 710032, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Yu</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>The State Key Laboratory of Cancer Biology and Department of Oncology, Xijing Hospital, The Fourth Military Medical University, Xi'an 710032, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wei</LastName>
                    <ForeName>Yifang</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>The State Key Laboratory of Cancer Biology and Department of Biochemistry and Molecular Biology, The Fourth Military Medical University, Xi'an 710032, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Mengyang</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>The State Key Laboratory of Cancer Biology and Department of Biochemistry and Molecular Biology, The Fourth Military Medical University, Xi'an 710032, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yu</LastName>
                    <ForeName>Shentong</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>The State Key Laboratory of Cancer Biology and Department of Biochemistry and Molecular Biology, The Fourth Military Medical University, Xi'an 710032, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ye</LastName>
                    <ForeName>Mingxiang</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pulmonary Medicine, Xijing Hospital, The Fourth Military Medical University, Xi'an 710032, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Hongmei</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>The State Key Laboratory of Cancer Biology and Department of Oncology, Xijing Hospital, The Fourth Military Medical University, Xi'an 710032, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Suning</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacy, Xijing Hospital, The Fourth Military Medical University, Xi'an 710032, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Wenchao</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>The State Key Laboratory of Cancer Biology and Department of Oncology, Xijing Hospital, The Fourth Military Medical University, Xi'an 710032, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Jian</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>The State Key Laboratory of Cancer Biology and Department of Biochemistry and Molecular Biology, The Fourth Military Medical University, Xi'an 710032, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2015</Year>
                <Month>10</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Sci Rep</MedlineTA>
            <NlmUniqueID>101563288</NlmUniqueID>
            <ISSNLinking>2045-2322</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C467559">CCP110 protein, human</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D018797">Cell Cycle Proteins</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D008869">Microtubule-Associated Proteins</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C541915">Mirn129 microRNA, human</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D010750">Phosphoproteins</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D043823">Taxoids</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>15H5577CQD</RegistryNumber>
                <NameOfSubstance UI="D000077143">Docetaxel</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018797" MajorTopicYN="N">Cell Cycle Proteins</DescriptorName>
                <QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000077143" MajorTopicYN="N">Docetaxel</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019008" MajorTopicYN="N">Drug Resistance, Neoplasm</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015972" MajorTopicYN="N">Gene Expression Regulation, Neoplastic</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D061986" MajorTopicYN="N">MCF-7 Cells</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D035683" MajorTopicYN="N">MicroRNAs</DescriptorName>
                <QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008869" MajorTopicYN="N">Microtubule-Associated Proteins</DescriptorName>
                <QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010750" MajorTopicYN="N">Phosphoproteins</DescriptorName>
                <QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D043823" MajorTopicYN="N">Taxoids</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D023041" MajorTopicYN="N">Xenograft Model Antitumor Assays</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2015</Year>
                <Month>04</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2015</Year>
                <Month>09</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2015</Year>
                <Month>10</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2015</Year>
                <Month>10</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2016</Year>
                <Month>9</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">26487539</ArticleId>
            <ArticleId IdType="pii">srep15424</ArticleId>
            <ArticleId IdType="doi">10.1038/srep15424</ArticleId>
            <ArticleId IdType="pmc">PMC4614026</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Chin J Cancer Res. 2014 Feb;26(1):48-58</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24653626</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2014 Aug 15;74(16):4482-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24962027</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2009 Jun 1;69(11):4851-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19487295</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2005 Aug 20;23(24):5542-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16110015</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Med Oncol. 2013 Mar;30(1):365</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23307240</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Breast Cancer Res. 2004;6(5):R601-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15318941</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oncogenesis. 2013 Jul 22;2:e57</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23877787</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>FEBS Lett. 2014 May 2;588(9):1644-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24631532</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2007 Aug 24;130(4):678-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17719545</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2009 Dec 1;69(23):9038-46</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19887623</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Methods. 2001 Dec;25(4):402-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11846609</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2006 Apr 10;24(11):1770-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16603719</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2002 Mar 15;20(6):1456-66</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11896092</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Drug Resist Updat. 2010 Jun;13(3):57-66</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20236855</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2004 Sep 16;431(7006):350-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15372042</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Opin Cell Biol. 1998 Feb;10(1):123-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9484604</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Drug Resist Updat. 2014 Apr;17(1-2):13-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24853766</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2904-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10688884</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2013;8(12):e81366</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24358111</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oncogenesis. 2012 Mar 12;1:e3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23552555</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Dev Cell. 2008 Aug;15(2):187-97</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18694559</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Cancer. 2010 Jan 1;126(1):2-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19634138</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Cell Biol. 2012 Jul;14(7):697-706</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22684256</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Anticancer Res. 1999 Jan-Feb;19(1A):535-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10226594</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Endocr Relat Cancer. 2011 Dec;18(6):711-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21946411</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2004 Apr 30;304(5671):734-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15118162</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Breast Cancer. 2006;13(1):8-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16518057</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Treat Rev. 2012 Nov;38(7):890-903</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22465195</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Cancer. 2008 Dec;44(18):2753-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19022662</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Cancer Res Clin Oncol. 2014 Aug;140(8):1295-304</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24802708</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2004 Jan 23;116(2):281-97</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14744438</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Med Mol Morphol. 2009 Jun;42(2):102-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19536617</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oncogenesis. 2013 Mar 25;2:e40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23552883</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2012;7(12):e48637</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23251334</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Biol Cell. 2006 Aug;17(8):3423-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16760425</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2415-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18272492</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oncologist. 2004;9 Suppl 2:3-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15161985</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Anticancer Res. 2014 Jul;34(7):3807-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24982406</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>CA Cancer J Clin. 2014 Jan-Feb;64(1):9-29</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24399786</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2012;7(4):e35800</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22536440</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lung Cancer. 2013 Feb;79(2):173-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23177020</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Death Dis. 2013;4:e659</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23744359</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Cancer. 2010 Jan;46(2):298-311</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19948396</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Annu Rev Biochem. 2000;69:277-302</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10966460</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Dig Dis. 2009 Aug;10(3):188-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19659786</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Dev Cell. 2002 Sep;3(3):339-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12361598</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Mol Med. 2013 Jul;32(1):51-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23677061</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>